Cargando…

CHKA mediates the poor prognosis of lung adenocarcinoma and acts as a prognostic indicator

Choline kinase α (CHKA), the enzyme that converts choline to phosphocholine, has been studied in human carcinogenesis widely. However, the expression and underlying clinicopathological characteristics of CHKA in lung adenocarcinoma remains elusive. In the present study, a tissue microarray of 119 pa...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Li, Chen, Ping, Yang, Shen, Li, Guodong, Bao, Wentao, Wu, Peng, Jiang, Shujuan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	D.A. Spandidos 2016
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4998128/ https://www.ncbi.nlm.nih.gov/pubmed/27588131 http://dx.doi.org/10.3892/ol.2016.4810

Ejemplares similares

Overexpression of CHKA contributes to tumor progression and metastasis and predicts poor prognosis in colorectal carcinoma
por: Hu, Liang, et al.
Publicado: (2016)

ERRα is an aggressive factor in lung adenocarcinoma indicating poor prognostic outcomes
por: Li, Ping, et al.
Publicado: (2019)

CHKA and PCYT1A gene polymorphisms, choline intake and spina bifida risk in a California population
por: Enaw, James O Ebot, et al.
Publicado: (2006)

High expression of DARS2 indicates poor prognosis in lung adenocarcinoma
por: Jiang, Yingfeng, et al.
Publicado: (2022)

Claudin‐1 correlates with poor prognosis in lung adenocarcinoma
por: Sun, Bing‐sheng, et al.
Publicado: (2016)

Loss of IL-34 Expression Indicates Poor Prognosis in Patients With Lung Adenocarcinoma
por: Wang, Zhendong, et al.
Publicado: (2021)

PIK3CA gene mutation associated with poor prognosis of lung adenocarcinoma
por: Zhang, Lina, et al.
Publicado: (2013)

High expression of 14-3-3ơ indicates poor prognosis and progression of lung adenocarcinoma
por: Feng, Junfei, et al.
Publicado: (2022)

Aquaporin 1 Is an Independent Marker of Poor Prognosis in Lung Adenocarcinoma
por: Yun, Sumi, et al.
Publicado: (2016)

ARNTL2 is an indicator of poor prognosis, promotes epithelial-to-mesenchymal transition and inhibits ferroptosis in lung adenocarcinoma
por: Zhang, Huan, et al.
Publicado: (2022)

miR-765 Acts as a Tumor Promoter and Indicates Poor Prognosis in Non-Small Cell Lung Cancer
por: Wang, Jiying, et al.
Publicado: (2021)

DDIT4 overexpression associates with poor prognosis in lung adenocarcinoma
por: Song, Li, et al.
Publicado: (2021)

Overexpression of CENPF is associated with progression and poor prognosis of lung adenocarcinoma
por: Li, Mei-Xiang, et al.
Publicado: (2021)

Moesin as a prognostic indicator of lung adenocarcinoma improves prognosis by enhancing immune lymphocyte infiltration
por: Li, Yan-Qi, et al.
Publicado: (2021)

Long Noncoding RNA RGMB-AS1 Indicates a Poor Prognosis and Modulates Cell Proliferation, Migration and Invasion in Lung Adenocarcinoma
por: Li, Ping, et al.
Publicado: (2016)

Notch Signaling Components: Diverging Prognostic Indicators in Lung Adenocarcinoma
por: Liu, Zhi-Yan, et al.
Publicado: (2016)

SIRT1 expression is associated with poor prognosis of lung adenocarcinoma
por: Li, Chong, et al.
Publicado: (2015)

The High Expression of PTPRH Is Associated with Poor Prognosis of Human Lung Adenocarcinoma
por: Chen, Aifeng, et al.
Publicado: (2021)

Platelet-lymphocyte ratio acts as an indicator of poor prognosis in patients with breast cancer
por: Zhu, Yanyun, et al.
Publicado: (2016)

VEGI downregulation is correlated with nodal metastasis and poor prognosis in lung adenocarcinoma
por: Xu, Yinhai, et al.
Publicado: (2021)

Coexistence of two missense mutations in the KRAS gene in adenocarcinoma of the lung: a possible indicator of poor prognosis
por: Spinelli, Manuela, et al.
Publicado: (2022)

High expression of prolyl 4-hydroxylase subunit alpha-2 in lung adenocarcinoma indicates poor prognosis
por: Lu, Xiao-Hong, et al.
Publicado: (2022)

Transketolase Serves as a Biomarker for Poor Prognosis in Human Lung Adenocarcinoma
por: Niu, Cong, et al.
Publicado: (2022)

High levels of serum glypican‐1 indicate poor prognosis in pancreatic ductal adenocarcinoma
por: Zhou, Cong‐ya, et al.
Publicado: (2018)

Plasminogen Activator Inhibitor 1 as a Poor Prognostic Indicator in Resectable Pancreatic Ductal Adenocarcinoma
por: Liu, Wen-Jing, et al.
Publicado: (2018)

High DSCC1 Level Predicts Poor Prognosis of Lung Adenocarcinoma
por: Chang, Sisi, et al.
Publicado: (2021)

High Expression of PSRC1 Predicts Poor Prognosis in Lung Adenocarcinoma
por: Han, Rui, et al.
Publicado: (2023)

Expression of CC chemokine receptor 9 predicts poor prognosis in patients with lung adenocarcinoma
por: Zhong, Yonglong, et al.
Publicado: (2015)

High CTHRC1 expression may be closely associated with angiogenesis and indicates poor prognosis in lung adenocarcinoma patients
por: Chen, Yangshan, et al.
Publicado: (2019)

TOP2A Promotes Lung Adenocarcinoma Cells' Malignant Progression and Predicts Poor Prognosis in Lung Adenocarcinoma
por: Kou, Fan, et al.
Publicado: (2020)

BPTF promotes tumor growth and predicts poor prognosis in lung adenocarcinomas
por: Dai, Meng, et al.
Publicado: (2015)

Pinin acts as a poor prognostic indicator for renal cell carcinoma by reducing apoptosis and promoting cell migration and invasion
por: Jin, Ming, et al.
Publicado: (2021)

CA916798 predicts poor prognosis and promotes Gefitinib resistance for lung adenocarcinoma
por: He, Jian, et al.
Publicado: (2023)

Low expression of NLRP1 is associated with a poor prognosis and immune infiltration in lung adenocarcinoma patients
por: Shen, Edward, et al.
Publicado: (2021)

FAM72 serves as a biomarker of poor prognosis in human lung adenocarcinoma
por: Yu, Yilin, et al.
Publicado: (2021)

Decreased INPP5B expression predicts poor prognosis in lung adenocarcinoma
por: Deng, Jun, et al.
Publicado: (2022)

miR-765 Acts as a Tumor Promoter and Indicates Poor Prognosis in Non-Small Cell Lung Cancer [Retraction]
Publicado: (2023)

Overexpression of MRPL19 in predicting poor prognosis and promoting the development of lung adenocarcinoma
por: Wei, Dong, et al.
Publicado: (2023)

High SNRPA1 expression leads to poor prognosis in patients with lung adenocarcinoma
por: Yang, Juan Juan, et al.
Publicado: (2023)

High Expression of DEPDC1B Predicts Poor Prognosis in Lung Adenocarcinoma
por: Li, Pulin, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_681aua5ur1aocjs5cosi65a5tb